Stablepoint Partners, LLC Merck & Co., Inc. Transaction History
Stablepoint Partners, LLC
- $630 Billion
- Q3 2025
A detailed history of Stablepoint Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stablepoint Partners, LLC holds 70,629 shares of MRK stock, worth $6.56 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
70,629
Previous 61,369
15.09%
Holding current value
$6.56 Million
Previous $4.86 Billion
22.02%
% of portfolio
0.94%
Previous 0.83%
Shares
8 transactions
Others Institutions Holding MRK
# of Institutions
3,878Shares Held
1.9BCall Options Held
31.1MPut Options Held
28.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...